CRMs for Biotech and Life Sciences

Biotech CRM is shaped by two things commercial CRMs barely acknowledge: the multi-stakeholder account model (a "customer" is rarely a single decision-maker — it's a principal investigator, a study coordinator, an IRB, a procurement officer, and an institutional purchasing committee, each with distinct preferences and approval gates), and regulatory record-keeping (every interaction with a clinical site or KOL may need to survive an FDA inspection or sponsor audit). Add the fact that biotech sales cycles often run 12–36 months across institutional decision processes, and the generic SaaS CRM motion — MQL → SQL → opportunity → close — doesn't have the shape of the business. The CRMs below either ship life-sciences-specific data models, or have the configurability and security posture to deploy into a regulated commercial-stage biotech without rebuilding from scratch.